no icon
no icon
amc icon

Mirae Asset Healthcare Fund - Regular Plan - Idcw Reinvestment

Equity | Sector Specific - Pharma

(NAV as of 16/04/2024)
21.40 (0.26)

3Y Returns

2.06%

Min SIP

500

Min Lumpsum

5000

Expense Ratio

2.09%

Fund Size

1723 Cr

Inception Date

02-Jul-18

Fund Manager

Vrijesh Kasera

Exit Load

1% on or before 1Y(365D), Nil after 1Y(365D).

Wealthzi View

Overall Fund Zi Tag

Asset Allocation

Equity

99.28%

Debt & Others

0.72%

Market Cap Allocation

Large Cap

55.28%

Mid Cap

26.29%

Small Cap

18.07%

Other Cap

0.36%

Sector Allocation

Pharmaceuticals

76.51%

Health Care

19.50%

Chemicals

2.21%

Insurance

1.24%

Cash/Deposits/Margins/Treps/Repo/Swaps

0.53%

Top Ten Holdings

Sun Pharmaceutical Industries Ltd

16.03%

Cipla Ltd

8.98%

Aurobindo Pharma Ltd

8.64%

Dr. Reddy'S Laboratories Ltd

8.00%

Apollo Hospitals Enterprises Ltd

6.55%

Investment Objective

The Investment Objective Of The Scheme Is To Seek To Generate Long Term Capital Appreciation Through Investing In Equity And Equity Related Securities Of Companies Benefitting Directly Or Indirectly In Healthcare And Allied Sectors In India. The Scheme Does Not Guarantee Or Assure Any Returns.

Fund House Detail

AMC Name

Mirae Asset Investment Managers (India) Private Limited

Address

Unit 606, 6th Floor, Windsor,Off CST Road, Kalina, Santacruz (E),Mumbai - 400 098

BUILD WEALTH WITH CONFIDENCE

no iconno iconno iconno icon
no icon

BSE Member code: 58371

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.
get on play storeget on app store

Wealthzi Investment Advisers (A division of Lime Internet Private Limited)

[CIN: U74999DL2017PTC310507] [PAN: AADCL2103M] [GSTIN: 07AADCL2103M1ZP]

[SEBI Registered Name: Lime Internet Private Limited] [SEBI RIA Registration No: INA000018133] [BASL Member ID: 2014] [Type of Registration: Non-Individual] [Validity of Registration: Perpetual] [Registered Address: Flat No. 603, 6th Floor, Kanchenjunga Building, 18 Barakhamba Road, New Delhi - 110001] [Principal Officer: Jyoti Prakash Nayak, Email: [email protected]] [Compliance Officer: Harshit Singh, Email: [email protected]] [Grievance Officer: Sahad PV, Email: [email protected]]

[SEBI Regional Office Address: Securities and Exchange Board of India, NBCC Complex, Office Tower-1, 8th Floor, Plate B, East Kidwai Nagar, New Delhi - 110023, Ph: 011-69012998, Email: [email protected]]

Disclaimers:

Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Registration granted by SEBI, membership of BASL and certification from National Institute of Securities Markets (NISM) in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The information is only for consumption by the client and such material should not be redistributed.